BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
53.30
-0.51 (-0.95%)
Apr 28, 2026, 4:00 PM EDT - Market closed
BioMarin Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 10,301 | 11,417 | 12,527 | 18,162 | 19,234 | 16,220 | Upgrade
|
| Market Cap Growth | -4.13% | -8.86% | -31.03% | -5.57% | 18.57% | 1.90% | Upgrade
|
| Enterprise Value | 9,384 | 10,544 | 12,199 | 18,132 | 19,051 | 16,229 | Upgrade
|
| Last Close Price | 53.30 | 59.43 | 65.73 | 96.42 | 103.49 | 88.35 | Upgrade
|
| PE Ratio | 29.53 | 32.72 | 29.35 | 108.34 | 135.87 | - | Upgrade
|
| Forward PE | 9.95 | 12.37 | 17.86 | 38.98 | 39.00 | 85.79 | Upgrade
|
| PS Ratio | 3.20 | 3.54 | 4.39 | 7.51 | 9.18 | 8.79 | Upgrade
|
| PB Ratio | 1.68 | 1.88 | 2.21 | 3.67 | 4.18 | 3.80 | Upgrade
|
| P/TBV Ratio | 1.85 | 2.05 | 2.44 | 4.10 | 4.73 | 4.41 | Upgrade
|
| P/FCF Ratio | 14.21 | 15.75 | 25.70 | 290.28 | 350.06 | 77.63 | Upgrade
|
| P/OCF Ratio | 12.44 | 13.79 | 21.87 | 114.04 | 109.34 | 53.26 | Upgrade
|
| PEG Ratio | 0.39 | 0.65 | 0.72 | 1.07 | 0.86 | 2.66 | Upgrade
|
| EV/Sales Ratio | 2.91 | 3.27 | 4.28 | 7.50 | 9.09 | 8.79 | Upgrade
|
| EV/EBITDA Ratio | 12.98 | 14.59 | 21.38 | 62.49 | 121.62 | 481.22 | Upgrade
|
| EV/EBIT Ratio | 14.42 | 16.20 | 25.73 | 97.60 | 348.42 | - | Upgrade
|
| EV/FCF Ratio | 12.94 | 14.54 | 25.03 | 289.80 | 346.74 | 77.67 | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.11 | 0.11 | 0.23 | 0.24 | 0.26 | Upgrade
|
| Debt / EBITDA Ratio | 0.88 | 0.88 | 1.08 | 3.73 | 6.58 | 23.56 | Upgrade
|
| Debt / FCF Ratio | 0.89 | 0.89 | 1.30 | 18.12 | 20.38 | 5.38 | Upgrade
|
| Net Debt / Equity Ratio | -0.15 | -0.15 | -0.09 | 0.01 | -0.04 | 0.03 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.27 | -1.27 | -0.88 | 0.21 | -1.10 | 3.25 | Upgrade
|
| Net Debt / FCF Ratio | -1.27 | -1.27 | -1.03 | 0.96 | -3.12 | 0.52 | Upgrade
|
| Asset Turnover | 0.44 | 0.44 | 0.41 | 0.37 | 0.34 | 0.31 | Upgrade
|
| Inventory Turnover | 1.20 | 1.20 | 1.14 | 1.28 | 1.38 | 1.49 | Upgrade
|
| Quick Ratio | 3.25 | 3.25 | 2.96 | 1.45 | 2.98 | 2.54 | Upgrade
|
| Current Ratio | 5.21 | 5.21 | 5.33 | 2.51 | 4.67 | 4.16 | Upgrade
|
| Return on Equity (ROE) | 5.94% | 5.94% | 8.05% | 3.51% | 3.19% | -1.53% | Upgrade
|
| Return on Assets (ROA) | 5.58% | 5.58% | 4.29% | 1.76% | 0.55% | -0.78% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.09% | 9.12% | 7.35% | 3.50% | 1.18% | -1.74% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.50% | 9.50% | 7.40% | 3.30% | 0.90% | -1.40% | Upgrade
|
| Earnings Yield | 3.39% | 3.06% | 3.41% | 0.92% | 0.74% | -0.40% | Upgrade
|
| FCF Yield | 7.04% | 6.35% | 3.89% | 0.34% | 0.29% | 1.29% | Upgrade
|
| Buyback Yield / Dilution | -0.35% | -0.35% | -2.67% | -1.39% | -3.34% | 4.61% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.